| P50 | author | William D. Leslie | Q37603772 |
| | Charles N Bernstein | Q88613774 |
| P2093 | author name string | Michael Sargent | |
| P2860 | cites work | Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells | Q24321566 |
| | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 |
| | Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. | Q33611312 |
| | Osteoprotegerin ligand: a regulator of immune responses and bone physiology. | Q34079327 |
| | Molecular control of bone remodeling and osteoporosis | Q34106530 |
| | AGA technical review on osteoporosis in gastrointestinal diseases. | Q34180733 |
| | Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy | Q34285067 |
| | AGA technical review on osteoporosis in hepatic disorders. | Q35209520 |
| | Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis | Q36599399 |
| | Serum osteoprotegerin but not receptor activator of NF-kappaB ligand correlates with Larsen score in rheumatoid arthritis | Q43049993 |
| | The association between corticosteroid use and development of fractures among IBD patients in a population-based database | Q44113788 |
| | Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women | Q44168040 |
| | Serum levels of osteoprotegerin increase with age in a healthy adult population | Q44480310 |
| | Serum osteoprotegerin in adolescent girls with anorexia nervosa | Q44547568 |
| | Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease | Q44618423 |
| | Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota | Q44770708 |
| | Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women | Q46130374 |
| | Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. | Q50571371 |
| | Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. | Q52859590 |
| | Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. | Q53897603 |
| | Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells | Q56964366 |
| | Inflammatory bowel disease and the risk of fracture | Q57086763 |
| P433 | issue | 4 | |
| P921 | main subject | Crohn's disease | Q1472 |
| P304 | page(s) | 325-330 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study | |
| P478 | volume | 11 | |